Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat

G. Vendemiale, V. Palmieri, G. Palasciano, E. Altomare

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Vendemiale G, Palmieri V, Palasciano G, Altomare E. Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. Scand J Gastroenterol 1994;29:1034-1038. Background: Since the effect of exogenous glutathione (GSH) on overall hepatic GSH homeostasis is not known, the present study investigated the changes in the hepatic, biliary, and plasmatic GSH levels during GSH administration in intact rats Methods: An exteriorized biliary-duodenal fistula was established, and GSH (1 mmol/kg over 2 h) or saline was administered intraperitoneally to rats with or without pretreatment with 5 mmol/kg L-serine borate, an inhibitor of gamma-glutamyltransferase (GGT). Results: Three hours after GSH administration, biliary GSH efflux and bile flow rose from 104.7 ± 5.6 to 290.6 ± 8.6μg/ml bile and from 20.2 ± 1.3 to 30.2 ± 2.1 μl/min, respectively; GSH-treated rats also showed increased liver (35% and posthepatic vein plasma (68% GSH concentrations compared with controls. By contrast, in rats pretreated with the GGT inhibitor GSH administration appeared to be devoid of any effect, except for a modest biliary GSH increase. Conclusions: This study indicates that significant changes occur in the hepatic GSH homeostasis after intraperitoneal GSH administration. The activity of hepatic GGT. most likely through degradation of circulating GSH, followed by an increase in cysteine availability, seems to account, at least partially, for the reported effects.

Original languageEnglish
Pages (from-to)1034-1038
Number of pages5
JournalScandinavian Journal of Gastroenterology
Volume29
Issue number11
DOIs
Publication statusPublished - 1994

Fingerprint

Glutathione
gamma-Glutamyltransferase
Liver
Bile
Homeostasis
Biliary Fistula
Borates
Serine
Cysteine
Veins

Keywords

  • Biliary and plasmatic glutathione efflux
  • Glutathione administration
  • Glutathione homeostasis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. / Vendemiale, G.; Palmieri, V.; Palasciano, G.; Altomare, E.

In: Scandinavian Journal of Gastroenterology, Vol. 29, No. 11, 1994, p. 1034-1038.

Research output: Contribution to journalArticle

Vendemiale, G. ; Palmieri, V. ; Palasciano, G. ; Altomare, E. / Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. In: Scandinavian Journal of Gastroenterology. 1994 ; Vol. 29, No. 11. pp. 1034-1038.
@article{7ba1ac66a4754222a2ede9f709d16c57,
title = "Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat",
abstract = "Vendemiale G, Palmieri V, Palasciano G, Altomare E. Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. Scand J Gastroenterol 1994;29:1034-1038. Background: Since the effect of exogenous glutathione (GSH) on overall hepatic GSH homeostasis is not known, the present study investigated the changes in the hepatic, biliary, and plasmatic GSH levels during GSH administration in intact rats Methods: An exteriorized biliary-duodenal fistula was established, and GSH (1 mmol/kg over 2 h) or saline was administered intraperitoneally to rats with or without pretreatment with 5 mmol/kg L-serine borate, an inhibitor of gamma-glutamyltransferase (GGT). Results: Three hours after GSH administration, biliary GSH efflux and bile flow rose from 104.7 ± 5.6 to 290.6 ± 8.6μg/ml bile and from 20.2 ± 1.3 to 30.2 ± 2.1 μl/min, respectively; GSH-treated rats also showed increased liver (35{\%} and posthepatic vein plasma (68{\%} GSH concentrations compared with controls. By contrast, in rats pretreated with the GGT inhibitor GSH administration appeared to be devoid of any effect, except for a modest biliary GSH increase. Conclusions: This study indicates that significant changes occur in the hepatic GSH homeostasis after intraperitoneal GSH administration. The activity of hepatic GGT. most likely through degradation of circulating GSH, followed by an increase in cysteine availability, seems to account, at least partially, for the reported effects.",
keywords = "Biliary and plasmatic glutathione efflux, Glutathione administration, Glutathione homeostasis",
author = "G. Vendemiale and V. Palmieri and G. Palasciano and E. Altomare",
year = "1994",
doi = "10.3109/00365529409094882",
language = "English",
volume = "29",
pages = "1034--1038",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat

AU - Vendemiale, G.

AU - Palmieri, V.

AU - Palasciano, G.

AU - Altomare, E.

PY - 1994

Y1 - 1994

N2 - Vendemiale G, Palmieri V, Palasciano G, Altomare E. Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. Scand J Gastroenterol 1994;29:1034-1038. Background: Since the effect of exogenous glutathione (GSH) on overall hepatic GSH homeostasis is not known, the present study investigated the changes in the hepatic, biliary, and plasmatic GSH levels during GSH administration in intact rats Methods: An exteriorized biliary-duodenal fistula was established, and GSH (1 mmol/kg over 2 h) or saline was administered intraperitoneally to rats with or without pretreatment with 5 mmol/kg L-serine borate, an inhibitor of gamma-glutamyltransferase (GGT). Results: Three hours after GSH administration, biliary GSH efflux and bile flow rose from 104.7 ± 5.6 to 290.6 ± 8.6μg/ml bile and from 20.2 ± 1.3 to 30.2 ± 2.1 μl/min, respectively; GSH-treated rats also showed increased liver (35% and posthepatic vein plasma (68% GSH concentrations compared with controls. By contrast, in rats pretreated with the GGT inhibitor GSH administration appeared to be devoid of any effect, except for a modest biliary GSH increase. Conclusions: This study indicates that significant changes occur in the hepatic GSH homeostasis after intraperitoneal GSH administration. The activity of hepatic GGT. most likely through degradation of circulating GSH, followed by an increase in cysteine availability, seems to account, at least partially, for the reported effects.

AB - Vendemiale G, Palmieri V, Palasciano G, Altomare E. Effect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the rat. Scand J Gastroenterol 1994;29:1034-1038. Background: Since the effect of exogenous glutathione (GSH) on overall hepatic GSH homeostasis is not known, the present study investigated the changes in the hepatic, biliary, and plasmatic GSH levels during GSH administration in intact rats Methods: An exteriorized biliary-duodenal fistula was established, and GSH (1 mmol/kg over 2 h) or saline was administered intraperitoneally to rats with or without pretreatment with 5 mmol/kg L-serine borate, an inhibitor of gamma-glutamyltransferase (GGT). Results: Three hours after GSH administration, biliary GSH efflux and bile flow rose from 104.7 ± 5.6 to 290.6 ± 8.6μg/ml bile and from 20.2 ± 1.3 to 30.2 ± 2.1 μl/min, respectively; GSH-treated rats also showed increased liver (35% and posthepatic vein plasma (68% GSH concentrations compared with controls. By contrast, in rats pretreated with the GGT inhibitor GSH administration appeared to be devoid of any effect, except for a modest biliary GSH increase. Conclusions: This study indicates that significant changes occur in the hepatic GSH homeostasis after intraperitoneal GSH administration. The activity of hepatic GGT. most likely through degradation of circulating GSH, followed by an increase in cysteine availability, seems to account, at least partially, for the reported effects.

KW - Biliary and plasmatic glutathione efflux

KW - Glutathione administration

KW - Glutathione homeostasis

UR - http://www.scopus.com/inward/record.url?scp=0028127167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028127167&partnerID=8YFLogxK

U2 - 10.3109/00365529409094882

DO - 10.3109/00365529409094882

M3 - Article

VL - 29

SP - 1034

EP - 1038

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - 11

ER -